- Pfizer acquires Pharmacia in $59bn all stock deal
- Pharmacia licenses Nastech's apomorphine; returns rights
- Schwarz licenses US rights to Nastech scopolamine gel
- Nastech gets $4mm in private placement
- Nastech raises $5mm privately
- Pfizer launches hostile bid for Warner-Lambert
- OSI Pharmaceuticals completes huge follow-on
- Glaxo, SmithKline merge
- Bayer and GlaxoSmithKline co-promote ED drug
- Lilly pays Icos $75mm up front to establish JV
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.